Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 6Lung Neoplasms 3Thyroid Neoplasms 2Thoracic Neoplasms 2Respiratory Tract Neoplasms 2Respiratory Tract Diseases 2Neoplasms, Nerve Tissue 2Neoplasms, Germ Cell and Embryonal 2Neoplasms by Site 2Neoplasms by Histologic Type 2Neoplasms 2Lung Diseases 2Head and Neck Neoplasms 2Gastrointestinal Neoplasms 2Carcinoma, Medullary 2Carcinoma, Bronchogenic 2Carcinoma 2Adenocarcinoma 2Thyroid Diseases 1Thyroid Cancer, Papillary 1Solid Tumors 1Neuroendocrine Tumors 1Neuroectodermal Tumors 1Neoplasms, Glandular and Epithelial 1Multiple Endocrine Neoplasia Type 2a 1Locally Advanced Thyroid Gland Carcinoma 1Intestinal Neoplasms 1Intestinal Diseases 1Gastrointestinal Diseases 1Endocrine System Diseases 1

Interventions

trametinib 1selpercatinib 1pralsetinib 1lenvatinib 1larotrectinib 1entrectinib 1dabrafenib 1anlotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Advanced Thyroid Cancer Patients Who Received Target Therapy × pralsetinib × Clear all
NCT06195228 2025-08-14

A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer

Fudan University

Phase 4 Recruiting
800 enrolled
EndocrineHead & Neck

Advanced Thyroid Cancer Patients Who Received Target Therapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡